Esperion Therapeutics Inc. (NASDAQ:ESPR) traded at $1.99 at close of the session on Monday, April 29, made an upward move of 4.74% on its previous day’s price.
Looking at the stock we see that its previous close was $1.90. In terms of its 52-week price range, ESPR has a high of $3.40 and a low of $0.70. The company’s stock has lost about -25.75% over that past 30 days.
Esperion Therapeutics Inc. has a market cap of $339.14 million. Estimates by analysts give the company expected earnings per share (EPS) of $0.05, with the EPS growth for the year raised at -$0.4 for 2024 and $0.05 for next year. These figures represent 80.30% and 112.50% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $84.51 million, with a low of $28.9 million and a high of $144.57 million. The median projection represents growth squeezing down to 247.40% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $265.13 million, or 127.90% up from figures reported last year.
On the other hand, looking at the outlook for the ESPR stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is -16.13% off its SMA20 and -17.14% from its 50-day simple moving average. The RSI (14) is pointing at 41.76 while the volatility over the past week is 7.57% and jumps to 11.21% over the past one month. The beta value is 0.88, while the average true range (ATR) is currently pointing at 0.23.
Coming back to Esperion Therapeutics Inc. (NASDAQ:ESPR), we note that the average 3-month trading volume was 6.23 million. Current shares outstanding are 170.42 million.
The insiders hold 1.10% of the company’s shares while institutions hold 48.27%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -33.44% down in year-to-date price movement.
